MEDTRONIC PLC (2M6.DE) Forecast, Price Target & Analyst Ratings
FRA:2M6 • IE00BTN1Y115
78.52 EUR
-1.99 (-2.47%)
Last: Mar 6, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDTRONIC PLC (2M6.DE).
Forecast Snapshot
Consensus Price Target
€95.91
+ 22.14% Upside
Next Earnings Forecast
Release DateMay 20, 2026
PeriodQ4 / 2026
EPS Estimate$1.68
Revenue Estimate9.75B
ChartMill Buy Consensus
76.32%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€95.91
Upside
+ 22.14%
From current price of €78.52 to mean target of €95.91, Based on 38 analyst forecasts
Low
€78.69
Median
€97.08
High
€111.15
Price Target Revisions
1 Month
0.80%
3 Months
8.29%
Price Target Summary
38 analysts have analysed 2M6.DE and the average price target is 95.91 EUR. This implies a price increase of 22.14% is expected in the next year compared to the current price of 78.52.
The average price target has been revised upward by 8.29% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
76.32%
2M6.DE was analyzed by 38 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about 2M6.DE.
In the previous month the buy percentage consensus was at a similar level.
2M6.DE was analyzed by 38 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-06-03 | Argus Research | Maintains | Buy |
| 2021-05-28 | Deutsche Bank | Maintains | Buy |
| 2021-05-28 | Oppenheimer | Maintains | Outperform |
| 2021-05-28 | SVB Leerink | Maintains | Market Perform |
| 2021-05-28 | Raymond James | Maintains | Outperform |
| 2021-05-28 | Citigroup | Maintains | Buy |
| 2021-05-25 | Barclays | Initiate | Equal-Weight |
| 2021-04-15 | Atlantic Equities | Initiate | Overweight |
| 2021-02-24 | SVB Leerink | Maintains | Market Perform |
| 2021-02-24 | Stifel | Maintains | Buy |
| 2021-02-24 | Raymond James | Maintains | Outperform |
| 2021-02-24 | Credit Suisse | Maintains | Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 20, 2026
PeriodQ4 / 2026
EPS Estimate$1.68
Revenue Estimate9.75B
Revenue Q2Q9.22%
EPS Q2Q3.72%
Number of Analysts28
Next Earnings Revisions
Revenue (1 Month)
-0.02%
Revenue (3 Months)
0.08%
EPS (1 Month)
-0.05%
EPS (3 Months)
-0.25%
Next Earnings Summary
2M6.DE is expected to report earnings on 5/20/2026. The consensus EPS estimate for the next earnings is 1.68 EUR and the consensus revenue estimate is 9.75B EUR.
The next earnings revenue estimate has been revised upward by 0.08% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.227B -1.45% | 32.364B 3.64% | 33.537B 3.62% | 36.526B 8.91% | 38.992B 6.75% | 40.965B 5.06% | 43.158B 5.35% | 45.325B 5.02% | |
| EBITDA YoY % growth | 9.043B -5.93% | 8.768B -3.04% | 9.436B 7.62% | 10.366B 9.86% | 11.181B 7.86% | 12.033B 7.62% | 13.041B 8.38% | 13.981B 7.21% | |
| EBIT YoY % growth | 6.346B -8.11% | 6.121B -3.55% | 6.575B 7.42% | 9.17B 39.47% | 9.84B 7.31% | 10.534B 7.05% | 11.331B 7.57% | 12.199B 7.66% | |
| Operating Margin | 20.32% | 18.91% | 19.61% | 25.11% | 25.24% | 25.71% | 26.25% | 26.91% | |
| EPS YoY % growth | 5.30 -5.69% | 5.21 -1.70% | 5.50 5.57% | 5.70 3.55% | 6.14 7.81% | 6.61 7.73% | 7.18 8.48% | 7.75 7.99% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.68 3.72% | 1.40 10.86% | 1.47 8.29% | 1.49 9.36% | 1.82 8.48% | 1.48 6.15% | 1.55 5.27% | 1.58 6.48% | 1.97 7.88% |
| Revenue Q2Q % growth | 9.75B 9.22% | 9.448B 10.65% | 9.522B 6.26% | 9.481B 5.15% | 10.264B 5.27% | 9.5B 0.55% | 9.991B 4.93% | 9.954B 4.99% | 10.848B 5.69% |
| EBITDA Q2Q % growth | 3.043B -34.69% | 2.548B 11.46% | 2.654B -16.85% | 2.714B -31.12% | 3.27B 7.46% | 2.723B 6.87% | 2.803B 5.61% | 2.991B 10.21% | 3.367B 2.97% |
| EBIT Q2Q % growth | 2.748B 52.84% | 2.25B 46.29% | 2.368B 39.38% | 2.386B 40.52% | 2.94B 6.99% | 2.408B 7.02% | 2.478B 4.65% | 2.603B 9.09% | 3.119B 6.09% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
6.38%
EPS Next 5 Year
6.08%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
6.24%
Revenue Next 5 Year
5.80%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
11.27%
EBIT Next 5 Year
9.23%
MEDTRONIC PLC / 2M6.DE Forecast FAQ
What is the average price target for MEDTRONIC PLC (2M6.DE) stock?
38 analysts have analysed 2M6.DE and the average price target is 95.91 EUR. This implies a price increase of 22.14% is expected in the next year compared to the current price of 78.52.
What is the next earnings date for 2M6 stock?
MEDTRONIC PLC (2M6.DE) will report earnings on 2026-05-20, after the market close.
What are the consensus estimates for MEDTRONIC PLC (2M6.DE) next earnings?
The consensus EPS estimate for the next earnings of MEDTRONIC PLC (2M6.DE) is 1.68 EUR and the consensus revenue estimate is 9.75B EUR.
What is the consensus rating for 2M6 stock?
The consensus rating for MEDTRONIC PLC (2M6.DE) is 76.3158 / 100 . This indicates that analysts generally have a positive outlook on the stock.